LinkedIn Network Updates, 4/24/2013

	LinkedIn Network Updates, Apr 17 - Apr 24 Updates from Your Extended Network Connect with them to see what they're up to Matt Boeckeler http://lnkd.in/uFy4xt AstraZeneca follows Pfizer for BIND's second cancer nano-drug deal of... AstraZeneca is set to pay up to $199 million to Cambrige biotech BIND Therapeutics for development of Accurin, a cancer nanomedicine based on a kinase inhibitor owned by AstraZeneca (NYSE: AZN). Connect with Matt · Comment Cheryl Winter, MS RD, MS APRN, CDE, BC-ADM, FNP Do you sneak #healthy foods like vegetables into your child's foods? http://ow.ly/kkamr Connect with Cheryl · Comment Charles Kirk http://lnkd.in/cWhSaU The 10 Books Guaranteed To Chage Your Mindset and Move You Forward Have you ever read a book that completely changed your thinking and actions moving forward?  Has a book been so powerful that you continue to implement it’s principles to this day?  Some books stick but most books admittedly don’t. I’ve read and... Connect with Charles · Comment (2) Stephanie Andrzejewski Interesting depiction of the pharmaceutical industry's pipeline. Not surprising oncology is big. http://lnkd.in/kUMC6Y Industry Atlas - Forbes A look at some of the hottest topics in six critical industries. Connect with Stephanie · Comment View All Updates
	You are receiving Network Updates emails. Unsubscribe. This email was intended for start292 almar (aasdfsdfsd at AstraZeneca). Learn why we included this. © 2013, LinkedIn Corporation. 2029 Stierlin Ct. Mountain View, CA 94043, USA